Patent application number | Description | Published |
20090202608 | Devices, formulations, and methods for delivery of multiple beneficial agents - The present invention relates to osmotic delivery devices, formulations, and methods for delivery of two or more beneficial agents. In one aspect, the present invention provides osmotic delivery devices useful for substantially concurrent administration of two or more beneficial agents. In another aspect, the present invention provides beneficial agent formulations for use in the osmotic delivery devices. The formulations include formulations wherein beneficial agents are soluble in the vehicle, suspension formulations comprising particle formulations of one or more beneficial agent, and combinations thereof. Further, methods for treatment of a variety of diseases or conditions using two or more beneficial agents are disclosed, wherein the methods are preferably practiced using the osmotic delivery devices and/or formulations of the invention. | 08-13-2009 |
20130090287 | Devices, Formulations, and Methods for Delivery of Multiple Beneficial Agents - The present invention relates to osmotic delivery devices, formulations, and methods for delivery of two or more beneficial agents. In one aspect, the present invention provides osmotic delivery devices useful for substantially concurrent administration of two or more beneficial agents. In another aspect, the present invention provides beneficial agent formulations for use in the osmotic delivery devices. The formulations include formulations wherein beneficial agents are soluble in the vehicle, suspension formulations comprising particle formulations of one or more beneficial agent, and combinations thereof. Further, methods for treatment of a variety of diseases or conditions using two or more beneficial agents are disclosed, wherein the methods are preferably practiced using the osmotic delivery devices and/or formulations of the invention. | 04-11-2013 |
Patent application number | Description | Published |
20090025363 | Vent for the lubricating oil system of a jet engine - The air exit hole of the vent line ( | 01-29-2009 |
20100155526 | AIRCRAFT WITH TAIL PROPELLER-ENGINE LAYOUT - An aircraft propeller-engine layout includes at least one engine ( | 06-24-2010 |
20100212285 | TURBOPROP PROPULSION UNIT WITH PUSHER PROPELLER - A turboprop propulsion unit includes at least one pusher propeller | 08-26-2010 |
20100215481 | RUNNING-GAP CONTROL SYSTEM OF AN AIRCRAFT GAS TURBINE - A running-gap control system of an aircraft gas turbine with a core engine including a turbine whose blade rows have a running gap | 08-26-2010 |
20110209458 | Aircraft gas turbine engine - The invention refers to an aircraft gas turbine engine including a core engine | 09-01-2011 |
20130086908 | GAS TURBINE COMBUSTION CHAMBER ARRANGEMENT OF AXIAL TYPE OF CONSTRUCTION - A gas-turbine combustion chamber arrangement includes a flame tube, a diffuser element arranged upstream of the flame tube in the flow direction, the diffuser element including an annular duct, and an axial compressor arranged upstream of the diffuser element. The diffuser element features an annular guide vane area in which guide vanes are arranged, which for redirecting an incoming flow are provided at an angle (α) in a range between 28° and 32° relative to a central axis of the gas turbine. Downstream of the guide vane area, a diffuser area is arranged, the diffuser area not being provided with flow-guiding elements affecting the flow, where burners arranged in the annular combustion chamber are provided with their burner axes at an angle (β) between 40° and 50° relative to the central axis. | 04-11-2013 |
20140150442 | GAS TURBINE CENTRIPETAL ANNULAR COMBUSTION CHAMBER AND METHOD FOR FLOW GUIDANCE - A gas-turbine combustion chamber arrangement includes at least one centrifugal compressor as well as one centripetal annular combustion chamber, with a stator vane arrangement being provided between the centrifugal compressor and the annular combustion chamber. The stator vane arrangement for diverting the air flowing out of the centrifugal compressor is designed at an angle α of 20° to 30°, preferably 25°, relative to the engine axis, so the airflow is passed at essentially this angle α to the combustion chamber. The inflow area into the combustion chamber for supplying air is designed at an angle of 20° to 30°, preferably 25°, relative to the meridional plane, and the center axes of the burners or of the injection nozzles of the combustion chamber are arranged inclined at an angle β of 30° to 40°, preferably 35°, relative to a meridional plane passing through the engine axis. | 06-05-2014 |
Patent application number | Description | Published |
20110288122 | Pharmaceutical Compositions and Administrations Thereof - The present invention relates to the use of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, solids forms, and pharmaceutical compositions thereof for the treatment of CFTR mediated diseases, particularly cystic fibrosis, in patients possessing specific genetic mutations. | 11-24-2011 |
20130090354 | Pharmaceutical Compositions and Administrations Thereof - The present invention relates to the use of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, solids forms, and pharmaceutical compositions thereof for the treatment of CFTR mediated diseases, particularly cystic fibrosis, in patients possessing specific genetic mutations. | 04-11-2013 |
20130331412 | Pharmaceutical Compositions and Administrations Thereof - The present invention relates to the use of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, solids forms, and pharmaceutical compositions thereof for the treatment of CFTR mediated diseases, particularly cystic fibrosis, in patients possessing specific genetic mutations. | 12-12-2013 |
20140142138 | PHARMACEUTICAL COMPOSITIONS AND ADMINISTRATIONS THEREOF - The present invention relates to the use of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, solids forms, and pharmaceutical compositions thereof for the treatment of CFTR mediated diseases, particularly cystic fibrosis, in patients possessing specific genetic mutations. | 05-22-2014 |
20140323521 | PHARMACEUTICAL COMPOSITIONS AND ADMINISTRATIONS THEREOF - The present invention relates to the use of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, solids forms, and pharmaceutical compositions thereof for the treatment of CFTR mediated diseases, particularly cystic fibrosis, in patients possessing specific genetic mutations. | 10-30-2014 |
20140336219 | Pharmaceutical Compositions and Administrations Thereof - The present invention relates to the use of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, solids forms, and pharmaceutical compositions thereof for the treatment of CFTR mediated diseases, particularly cystic fibrosis, in patients possessing specific genetic mutations. | 11-13-2014 |